OUR MISSION
Bridging the vaccine gap in Africa with innovation, equity, and impact—one community at a time.
Together, let’s Be Lunacious and rewrite the story of global health.
Our Goals: Innovate With Us
Join us in transforming vaccine access across Nigeria and Africa. We're tackling malaria, Tuberculosis (TB), pneumococcal disease, Haemophilus influenza type b (Hib), HPV, rotavirus, yellow fever, polio, measles, hepatitis B, and DTP (diphtheria, tetanus, and pertussis). Through local production, we reduce import dependency, build stronger supply chains, and deliver life-saving vaccines. We work alongside top scientists, passionate researchers, and impact partners. Innovate with us. Learn More.
Vaccine Patches: Painless, Powerful, Needle-Free
LunaVax is introducing microneedle patches—a painless, needle-free way to deliver vaccines. Ideal for remote areas, they support our drone deliveries and mobile units. We're prioritizing vaccines for HPV, TB, and malaria—diseases that impact Nigerians the most—to make immunization safer, simpler, and more accessible. Learn more about microneedle patches from Gavi.
News and Insights
Transforming Vaccine Accessibility in Africa—read the full article.
Stay updated on our latest breakthroughs! Explore our latest insights on vaccine innovation, partnerships, and funding.
Partnerships
LunaVax is on a mission to establish local vaccine production and strengthen immunization programs in Nigeria and Africa. We seek partners, funding, and collaborators—from global health organizations to research institutions, governments, and private sector investors—to bridge the gap, drive innovation, and save lives. Learn more.
Vaccine Drones: Reaching the Unreachable
In the fight for equitable healthcare, vaccine drones are revolutionizing last-mile delivery. LunaVax is integrating drone logistics to transport vaccines to remote and underserved communities, breaking down barriers of geography and infrastructure. Learn more.
Our Vaccine Technologies
We harness cutting-edge platforms—mRNA, self-amplifying RNA (saRNA), protein subunit, viral vector, and DNA-based vaccines—to develop safe, scalable solutions for Africa’s most pressing vaccine-preventable diseases. These platforms support Nigeria’s immunization priorities while driving innovation for measles, TB, yellow fever, and rotavirus, where traditional methods still dominate. Learn more.
Mobile Vaccination Units: Expanding Access
Expanding immunization access starts on the community level. Our mobile vaccination units — including vaccine vans and pop-up clinics reach underserved communities by bringing vaccines directly to remote areas. This eliminates barriers to healthcare and ensuring life-saving immunizations. Learn more.